BrainSpec is built for your research needs
BrainSpec reduces the vendor-specific variability that has historically limited MR spectroscopy adoption in clinical trials.
Reproducible, quantitative MRS analysis across sites using harmonized processing pipelines reduces inter-operator variability.
Multi-vendor support for GE, Siemens, and Philips scanners ensures consistent data.
Built-in QC checks flag substandard acquisitions or poor quality, ensuring data integrity.
Access from anywhere with centralized data management. No local software installations required across research sites.
Compare patient data against reference intervals for objective, quantitative assessment of metabolite levels.
The biggest challenge in multi-site MR spectroscopy research is consistency. BrainSpec was built to solve this.
MR spectroscopy biomarkers unlock a wide range of research applications, from established indications to novel discovery.
Utilize BrainSpec Core™ existing FDA-clearance across a broad range of neurological conditions, applied in the clinical trial world.
Leverage the BrainSpec team’s 30+ years of spectroscopy expertise for study protocol design and research support into novel chemical signatures.
Track metabolite concentrations over time to objectively measure the neurochemical changes in the brain.
Support treatment response monitoring of chemical changes in advance of anatomical changes. [1]
[1]
Simicic et al., Clin Cancer Res 32(15):3258–3268, 2026
488 clinical trials found using MRS as a biomarker endpoint.
View publication